Brian Cherry

Board Member

Equibles does not estimate personal net worth.

Get an email with a short summary when Zymeworks Inc. publishes a filing, an earnings call transcript or a press release.

Get ZYME alerts

About Brian Cherry

Brian Cherry is recorded as Board Member at Zymeworks Inc. (ZYME) since January 12, 2026. Zymeworks Inc. reported in an 8-K filed January 12, 2026 that Brian Cherry was appointed Class II director, effective January 12, 2026. Zymeworks Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Zymeworks Inc. includes Ali Tehrani (CEO), Kenneth Galbraith (CEO and CFO), Kristin Stafford (CFO) and 7 others.

“On January 9, 2026, the board of directors (the "Board") of the Company, upon recommendation from the nominating and corporate governance committee of the Board appointed Mr. Brian Cherry as a Class II director of the Company effective January 12, 2026, with a term expiring at the Company's 2026 annual general meeting of stockholders.”

Zymeworks Inc. Form 8-K, filed January 12, 2026 · Read the filing

Affiliation history

Zymeworks Inc. (ZYME)
Board Member

SEC 8-K

Current
2026-01-12–present

Company network

Zymeworks Inc.

ZYME

Current role

Biotechnology · Healthcare

Board Member

2026-01-12–present

Leadership on record at Zymeworks Inc.

Ali Tehrani CEO
Kenneth Galbraith CEO, CFO
Kristin Stafford CFO
Leone Patterson CFO
Mark Hollywood COO
Scott Platshon CIO, Board Member
Paul Schneider General Counsel
Alessandra Cesano Board Member
Carlos Campoy Board Member
Derek Miller Board Member

Recent activity

Executive change Appointed: Class II director Zymeworks Inc. (ZYME)
2026-01-12